復星醫藥(02196.HK):李東明辭任聯席總裁職務
格隆匯1月4日丨復星醫藥(02196.HK)發佈公吿,2022年1月4日,公司第八屆董事會第六十一次會議選舉執行董事王可心先生、執行董事關曉暉女士擔任公司第八屆董事會副董事長。因該等任職變動,王可心先生向公司董事會提交了關於辭任聯席總裁、首席投資官的書面函,關曉暉女士向公司董事會提交了關於辭任執行總裁、首席財務官的書面函;自2022年1月4日起,王可心先生、關曉暉女士不再兼任上述職務。
此外,近日公司董事會分別收到李東明先生、汪曜先生的辭職函。因個人原因,李東明先生向公司董事會申請辭去聯席總裁職務;因工作安排調整,汪曜先生向公司董事會申請辭去副總裁職務。自2022年1月4日起,李東明先生、汪曜先生不再擔任上述高級管理人員職務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.